Ursula Pertl
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Virus-based gene therapy research, Neuroblastoma Research and Treatments, CAR-T cell therapy research, vaccines and immunoinformatics approaches
Most-Cited Works
- → A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth(2002)376 cited
- → IFN-γ-Inducible Protein-10 Is Essential for the Generation of a Protective Tumor-Specific CD8 T Cell Response Induced by Single-Chain IL-12 Gene Therapy(2001)107 cited
- → In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy(2001)98 cited
- → Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 Trial(1998)65 cited
- → Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma(2000)60 cited
- MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.(2001)
- Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.(2001)
- → Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma(2002)45 cited
- → Melanoma immunotherapy by targeted IL-2 depends on CD4+ T-cell help mediated by CD40/CD40L interaction(2000)41 cited